newsfilter
← Latest News
ClinicalTrials.gov·

Safety and Tolerability, Pharmacokinetic, and Pharmacodynamic Study of ALXN1920 in Healthy Participants - NCT05751642

Number of participants with Adverse events (AEs), Maximum observed concentration (Cmax), Time to maximum observed concentration (tmax), (and 15 more...)